The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Angiotensin Receptor Antagonists Market Research Report 2024
Synopsis
Angiotensin II receptor antagonists are a group of pharmaceuticals that modulate the renin–angiotensin system. Their main uses are in the treatment of hypertension (high blood pressure), diabetic nephropathy (kidney damage due to diabetes) and congestive heart failure. They block the activation of AT1receptors, preventing the binding of angiotensin II.
The global Angiotensin Receptor Antagonists market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Angiotensin Receptor Antagonists, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Angiotensin Receptor Antagonists.
Report Scope
The Angiotensin Receptor Antagonists market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Angiotensin Receptor Antagonists market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Angiotensin Receptor Antagonists manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Novartis
Merck
Astra Zeneca
Jhonson and Johnson
Eli Lilly
Sanofi
Bristol-Myers Squibb
Bayer
GSK
Teva Pharmaceutical
Segment by Type
Valsartan
Telmisartan
Losartan
Irbesartan
Azilsartan
Olmesartan
Segment by Application
Hypertension
Cardiovascular Diseases
Kidney Diseases
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Angiotensin Receptor Antagonists manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Angiotensin Receptor Antagonists in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Angiotensin II receptor antagonists are a group of pharmaceuticals that modulate the renin–angiotensin system. Their main uses are in the treatment of hypertension (high blood pressure), diabetic nephropathy (kidney damage due to diabetes) and congestive heart failure. They block the activation of AT1receptors, preventing the binding of angiotensin II.
The global Angiotensin Receptor Antagonists market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Angiotensin Receptor Antagonists, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Angiotensin Receptor Antagonists.
Report Scope
The Angiotensin Receptor Antagonists market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Angiotensin Receptor Antagonists market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Angiotensin Receptor Antagonists manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Novartis
Merck
Astra Zeneca
Jhonson and Johnson
Eli Lilly
Sanofi
Bristol-Myers Squibb
Bayer
GSK
Teva Pharmaceutical
Segment by Type
Valsartan
Telmisartan
Losartan
Irbesartan
Azilsartan
Olmesartan
Segment by Application
Hypertension
Cardiovascular Diseases
Kidney Diseases
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Angiotensin Receptor Antagonists manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Angiotensin Receptor Antagonists in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Angiotensin Receptor Antagonists Market Overview
1.1 Product Overview and Scope of Angiotensin Receptor Antagonists
1.2 Angiotensin Receptor Antagonists Segment by Type
1.2.1 Global Angiotensin Receptor Antagonists Market Value Comparison by Type (2024-2030)
1.2.2 Valsartan
1.2.3 Telmisartan
1.2.4 Losartan
1.2.5 Irbesartan
1.2.6 Azilsartan
1.2.7 Olmesartan
1.3 Angiotensin Receptor Antagonists Segment by Application
1.3.1 Global Angiotensin Receptor Antagonists Market Value by Application: (2024-2030)
1.3.2 Hypertension
1.3.3 Cardiovascular Diseases
1.3.4 Kidney Diseases
1.3.5 Other
1.4 Global Angiotensin Receptor Antagonists Market Size Estimates and Forecasts
1.4.1 Global Angiotensin Receptor Antagonists Revenue 2019-2030
1.4.2 Global Angiotensin Receptor Antagonists Sales 2019-2030
1.4.3 Global Angiotensin Receptor Antagonists Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Angiotensin Receptor Antagonists Market Competition by Manufacturers
2.1 Global Angiotensin Receptor Antagonists Sales Market Share by Manufacturers (2019-2024)
2.2 Global Angiotensin Receptor Antagonists Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Angiotensin Receptor Antagonists Average Price by Manufacturers (2019-2024)
2.4 Global Angiotensin Receptor Antagonists Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Angiotensin Receptor Antagonists, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Angiotensin Receptor Antagonists, Product Type & Application
2.7 Angiotensin Receptor Antagonists Market Competitive Situation and Trends
2.7.1 Angiotensin Receptor Antagonists Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Angiotensin Receptor Antagonists Players Market Share by Revenue
2.7.3 Global Angiotensin Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Angiotensin Receptor Antagonists Retrospective Market Scenario by Region
3.1 Global Angiotensin Receptor Antagonists Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Angiotensin Receptor Antagonists Global Angiotensin Receptor Antagonists Sales by Region: 2019-2030
3.2.1 Global Angiotensin Receptor Antagonists Sales by Region: 2019-2024
3.2.2 Global Angiotensin Receptor Antagonists Sales by Region: 2025-2030
3.3 Global Angiotensin Receptor Antagonists Global Angiotensin Receptor Antagonists Revenue by Region: 2019-2030
3.3.1 Global Angiotensin Receptor Antagonists Revenue by Region: 2019-2024
3.3.2 Global Angiotensin Receptor Antagonists Revenue by Region: 2025-2030
3.4 North America Angiotensin Receptor Antagonists Market Facts & Figures by Country
3.4.1 North America Angiotensin Receptor Antagonists Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Angiotensin Receptor Antagonists Sales by Country (2019-2030)
3.4.3 North America Angiotensin Receptor Antagonists Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Angiotensin Receptor Antagonists Market Facts & Figures by Country
3.5.1 Europe Angiotensin Receptor Antagonists Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Angiotensin Receptor Antagonists Sales by Country (2019-2030)
3.5.3 Europe Angiotensin Receptor Antagonists Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Angiotensin Receptor Antagonists Market Facts & Figures by Country
3.6.1 Asia Pacific Angiotensin Receptor Antagonists Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Angiotensin Receptor Antagonists Sales by Country (2019-2030)
3.6.3 Asia Pacific Angiotensin Receptor Antagonists Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Angiotensin Receptor Antagonists Market Facts & Figures by Country
3.7.1 Latin America Angiotensin Receptor Antagonists Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Angiotensin Receptor Antagonists Sales by Country (2019-2030)
3.7.3 Latin America Angiotensin Receptor Antagonists Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Angiotensin Receptor Antagonists Market Facts & Figures by Country
3.8.1 Middle East and Africa Angiotensin Receptor Antagonists Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Angiotensin Receptor Antagonists Sales by Country (2019-2030)
3.8.3 Middle East and Africa Angiotensin Receptor Antagonists Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Angiotensin Receptor Antagonists Sales by Type (2019-2030)
4.1.1 Global Angiotensin Receptor Antagonists Sales by Type (2019-2024)
4.1.2 Global Angiotensin Receptor Antagonists Sales by Type (2025-2030)
4.1.3 Global Angiotensin Receptor Antagonists Sales Market Share by Type (2019-2030)
4.2 Global Angiotensin Receptor Antagonists Revenue by Type (2019-2030)
4.2.1 Global Angiotensin Receptor Antagonists Revenue by Type (2019-2024)
4.2.2 Global Angiotensin Receptor Antagonists Revenue by Type (2025-2030)
4.2.3 Global Angiotensin Receptor Antagonists Revenue Market Share by Type (2019-2030)
4.3 Global Angiotensin Receptor Antagonists Price by Type (2019-2030)
5 Segment by Application
5.1 Global Angiotensin Receptor Antagonists Sales by Application (2019-2030)
5.1.1 Global Angiotensin Receptor Antagonists Sales by Application (2019-2024)
5.1.2 Global Angiotensin Receptor Antagonists Sales by Application (2025-2030)
5.1.3 Global Angiotensin Receptor Antagonists Sales Market Share by Application (2019-2030)
5.2 Global Angiotensin Receptor Antagonists Revenue by Application (2019-2030)
5.2.1 Global Angiotensin Receptor Antagonists Revenue by Application (2019-2024)
5.2.2 Global Angiotensin Receptor Antagonists Revenue by Application (2025-2030)
5.2.3 Global Angiotensin Receptor Antagonists Revenue Market Share by Application (2019-2030)
5.3 Global Angiotensin Receptor Antagonists Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Angiotensin Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Angiotensin Receptor Antagonists Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Corporation Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Angiotensin Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Novartis Angiotensin Receptor Antagonists Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Angiotensin Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck Angiotensin Receptor Antagonists Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Astra Zeneca
6.4.1 Astra Zeneca Corporation Information
6.4.2 Astra Zeneca Description and Business Overview
6.4.3 Astra Zeneca Angiotensin Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Astra Zeneca Angiotensin Receptor Antagonists Product Portfolio
6.4.5 Astra Zeneca Recent Developments/Updates
6.5 Jhonson and Johnson
6.5.1 Jhonson and Johnson Corporation Information
6.5.2 Jhonson and Johnson Description and Business Overview
6.5.3 Jhonson and Johnson Angiotensin Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Jhonson and Johnson Angiotensin Receptor Antagonists Product Portfolio
6.5.5 Jhonson and Johnson Recent Developments/Updates
6.6 Eli Lilly
6.6.1 Eli Lilly Corporation Information
6.6.2 Eli Lilly Description and Business Overview
6.6.3 Eli Lilly Angiotensin Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Eli Lilly Angiotensin Receptor Antagonists Product Portfolio
6.6.5 Eli Lilly Recent Developments/Updates
6.7 Sanofi
6.6.1 Sanofi Corporation Information
6.6.2 Sanofi Description and Business Overview
6.6.3 Sanofi Angiotensin Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sanofi Angiotensin Receptor Antagonists Product Portfolio
6.7.5 Sanofi Recent Developments/Updates
6.8 Bristol-Myers Squibb
6.8.1 Bristol-Myers Squibb Corporation Information
6.8.2 Bristol-Myers Squibb Description and Business Overview
6.8.3 Bristol-Myers Squibb Angiotensin Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Bristol-Myers Squibb Angiotensin Receptor Antagonists Product Portfolio
6.8.5 Bristol-Myers Squibb Recent Developments/Updates
6.9 Bayer
6.9.1 Bayer Corporation Information
6.9.2 Bayer Description and Business Overview
6.9.3 Bayer Angiotensin Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Bayer Angiotensin Receptor Antagonists Product Portfolio
6.9.5 Bayer Recent Developments/Updates
6.10 GSK
6.10.1 GSK Corporation Information
6.10.2 GSK Description and Business Overview
6.10.3 GSK Angiotensin Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.10.4 GSK Angiotensin Receptor Antagonists Product Portfolio
6.10.5 GSK Recent Developments/Updates
6.11 Teva Pharmaceutical
6.11.1 Teva Pharmaceutical Corporation Information
6.11.2 Teva Pharmaceutical Angiotensin Receptor Antagonists Description and Business Overview
6.11.3 Teva Pharmaceutical Angiotensin Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Teva Pharmaceutical Angiotensin Receptor Antagonists Product Portfolio
6.11.5 Teva Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Angiotensin Receptor Antagonists Industry Chain Analysis
7.2 Angiotensin Receptor Antagonists Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Angiotensin Receptor Antagonists Production Mode & Process
7.4 Angiotensin Receptor Antagonists Sales and Marketing
7.4.1 Angiotensin Receptor Antagonists Sales Channels
7.4.2 Angiotensin Receptor Antagonists Distributors
7.5 Angiotensin Receptor Antagonists Customers
8 Angiotensin Receptor Antagonists Market Dynamics
8.1 Angiotensin Receptor Antagonists Industry Trends
8.2 Angiotensin Receptor Antagonists Market Drivers
8.3 Angiotensin Receptor Antagonists Market Challenges
8.4 Angiotensin Receptor Antagonists Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Angiotensin Receptor Antagonists Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Angiotensin Receptor Antagonists Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Angiotensin Receptor Antagonists Market Competitive Situation by Manufacturers in 2023
Table 4. Global Angiotensin Receptor Antagonists Sales (K MT) of Key Manufacturers (2019-2024)
Table 5. Global Angiotensin Receptor Antagonists Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Angiotensin Receptor Antagonists Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Angiotensin Receptor Antagonists Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Angiotensin Receptor Antagonists Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Angiotensin Receptor Antagonists, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Angiotensin Receptor Antagonists, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Angiotensin Receptor Antagonists, Product Type & Application
Table 12. Global Key Manufacturers of Angiotensin Receptor Antagonists, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Angiotensin Receptor Antagonists by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Angiotensin Receptor Antagonists as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Angiotensin Receptor Antagonists Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Angiotensin Receptor Antagonists Sales by Region (2019-2024) & (K MT)
Table 18. Global Angiotensin Receptor Antagonists Sales Market Share by Region (2019-2024)
Table 19. Global Angiotensin Receptor Antagonists Sales by Region (2025-2030) & (K MT)
Table 20. Global Angiotensin Receptor Antagonists Sales Market Share by Region (2025-2030)
Table 21. Global Angiotensin Receptor Antagonists Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Angiotensin Receptor Antagonists Revenue Market Share by Region (2019-2024)
Table 23. Global Angiotensin Receptor Antagonists Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Angiotensin Receptor Antagonists Revenue Market Share by Region (2025-2030)
Table 25. North America Angiotensin Receptor Antagonists Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Angiotensin Receptor Antagonists Sales by Country (2019-2024) & (K MT)
Table 27. North America Angiotensin Receptor Antagonists Sales by Country (2025-2030) & (K MT)
Table 28. North America Angiotensin Receptor Antagonists Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Angiotensin Receptor Antagonists Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Angiotensin Receptor Antagonists Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Angiotensin Receptor Antagonists Sales by Country (2019-2024) & (K MT)
Table 32. Europe Angiotensin Receptor Antagonists Sales by Country (2025-2030) & (K MT)
Table 33. Europe Angiotensin Receptor Antagonists Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Angiotensin Receptor Antagonists Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Angiotensin Receptor Antagonists Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Angiotensin Receptor Antagonists Sales by Region (2019-2024) & (K MT)
Table 37. Asia Pacific Angiotensin Receptor Antagonists Sales by Region (2025-2030) & (K MT)
Table 38. Asia Pacific Angiotensin Receptor Antagonists Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Angiotensin Receptor Antagonists Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Angiotensin Receptor Antagonists Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Angiotensin Receptor Antagonists Sales by Country (2019-2024) & (K MT)
Table 42. Latin America Angiotensin Receptor Antagonists Sales by Country (2025-2030) & (K MT)
Table 43. Latin America Angiotensin Receptor Antagonists Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Angiotensin Receptor Antagonists Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Angiotensin Receptor Antagonists Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Angiotensin Receptor Antagonists Sales by Country (2019-2024) & (K MT)
Table 47. Middle East & Africa Angiotensin Receptor Antagonists Sales by Country (2025-2030) & (K MT)
Table 48. Middle East & Africa Angiotensin Receptor Antagonists Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Angiotensin Receptor Antagonists Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Angiotensin Receptor Antagonists Sales (K MT) by Type (2019-2024)
Table 51. Global Angiotensin Receptor Antagonists Sales (K MT) by Type (2025-2030)
Table 52. Global Angiotensin Receptor Antagonists Sales Market Share by Type (2019-2024)
Table 53. Global Angiotensin Receptor Antagonists Sales Market Share by Type (2025-2030)
Table 54. Global Angiotensin Receptor Antagonists Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Angiotensin Receptor Antagonists Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Angiotensin Receptor Antagonists Revenue Market Share by Type (2019-2024)
Table 57. Global Angiotensin Receptor Antagonists Revenue Market Share by Type (2025-2030)
Table 58. Global Angiotensin Receptor Antagonists Price (USD/MT) by Type (2019-2024)
Table 59. Global Angiotensin Receptor Antagonists Price (USD/MT) by Type (2025-2030)
Table 60. Global Angiotensin Receptor Antagonists Sales (K MT) by Application (2019-2024)
Table 61. Global Angiotensin Receptor Antagonists Sales (K MT) by Application (2025-2030)
Table 62. Global Angiotensin Receptor Antagonists Sales Market Share by Application (2019-2024)
Table 63. Global Angiotensin Receptor Antagonists Sales Market Share by Application (2025-2030)
Table 64. Global Angiotensin Receptor Antagonists Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Angiotensin Receptor Antagonists Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Angiotensin Receptor Antagonists Revenue Market Share by Application (2019-2024)
Table 67. Global Angiotensin Receptor Antagonists Revenue Market Share by Application (2025-2030)
Table 68. Global Angiotensin Receptor Antagonists Price (USD/MT) by Application (2019-2024)
Table 69. Global Angiotensin Receptor Antagonists Price (USD/MT) by Application (2025-2030)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Angiotensin Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 73. Pfizer Angiotensin Receptor Antagonists Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Novartis Corporation Information
Table 76. Novartis Description and Business Overview
Table 77. Novartis Angiotensin Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 78. Novartis Angiotensin Receptor Antagonists Product
Table 79. Novartis Recent Developments/Updates
Table 80. Merck Corporation Information
Table 81. Merck Description and Business Overview
Table 82. Merck Angiotensin Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 83. Merck Angiotensin Receptor Antagonists Product
Table 84. Merck Recent Developments/Updates
Table 85. Astra Zeneca Corporation Information
Table 86. Astra Zeneca Description and Business Overview
Table 87. Astra Zeneca Angiotensin Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 88. Astra Zeneca Angiotensin Receptor Antagonists Product
Table 89. Astra Zeneca Recent Developments/Updates
Table 90. Jhonson and Johnson Corporation Information
Table 91. Jhonson and Johnson Description and Business Overview
Table 92. Jhonson and Johnson Angiotensin Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 93. Jhonson and Johnson Angiotensin Receptor Antagonists Product
Table 94. Jhonson and Johnson Recent Developments/Updates
Table 95. Eli Lilly Corporation Information
Table 96. Eli Lilly Description and Business Overview
Table 97. Eli Lilly Angiotensin Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 98. Eli Lilly Angiotensin Receptor Antagonists Product
Table 99. Eli Lilly Recent Developments/Updates
Table 100. Sanofi Corporation Information
Table 101. Sanofi Description and Business Overview
Table 102. Sanofi Angiotensin Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 103. Sanofi Angiotensin Receptor Antagonists Product
Table 104. Sanofi Recent Developments/Updates
Table 105. Bristol-Myers Squibb Corporation Information
Table 106. Bristol-Myers Squibb Description and Business Overview
Table 107. Bristol-Myers Squibb Angiotensin Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 108. Bristol-Myers Squibb Angiotensin Receptor Antagonists Product
Table 109. Bristol-Myers Squibb Recent Developments/Updates
Table 110. Bayer Corporation Information
Table 111. Bayer Description and Business Overview
Table 112. Bayer Angiotensin Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 113. Bayer Angiotensin Receptor Antagonists Product
Table 114. Bayer Recent Developments/Updates
Table 115. GSK Corporation Information
Table 116. GSK Description and Business Overview
Table 117. GSK Angiotensin Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 118. GSK Angiotensin Receptor Antagonists Product
Table 119. GSK Recent Developments/Updates
Table 120. Teva Pharmaceutical Corporation Information
Table 121. Teva Pharmaceutical Description and Business Overview
Table 122. Teva Pharmaceutical Angiotensin Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 123. Teva Pharmaceutical Angiotensin Receptor Antagonists Product
Table 124. Teva Pharmaceutical Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Angiotensin Receptor Antagonists Distributors List
Table 128. Angiotensin Receptor Antagonists Customers List
Table 129. Angiotensin Receptor Antagonists Market Trends
Table 130. Angiotensin Receptor Antagonists Market Drivers
Table 131. Angiotensin Receptor Antagonists Market Challenges
Table 132. Angiotensin Receptor Antagonists Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Angiotensin Receptor Antagonists
Figure 2. Global Angiotensin Receptor Antagonists Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Angiotensin Receptor Antagonists Market Share by Type in 2023 & 2030
Figure 4. Valsartan Product Picture
Figure 5. Telmisartan Product Picture
Figure 6. Losartan Product Picture
Figure 7. Irbesartan Product Picture
Figure 8. Azilsartan Product Picture
Figure 9. Olmesartan Product Picture
Figure 10. Global Angiotensin Receptor Antagonists Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 11. Global Angiotensin Receptor Antagonists Market Share by Application in 2023 & 2030
Figure 12. Hypertension
Figure 13. Cardiovascular Diseases
Figure 14. Kidney Diseases
Figure 15. Other
Figure 16. Global Angiotensin Receptor Antagonists Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Angiotensin Receptor Antagonists Market Size (2019-2030) & (US$ Million)
Figure 18. Global Angiotensin Receptor Antagonists Sales (2019-2030) & (K MT)
Figure 19. Global Angiotensin Receptor Antagonists Average Price (USD/MT) & (2019-2030)
Figure 20. Angiotensin Receptor Antagonists Report Years Considered
Figure 21. Angiotensin Receptor Antagonists Sales Share by Manufacturers in 2023
Figure 22. Global Angiotensin Receptor Antagonists Revenue Share by Manufacturers in 2023
Figure 23. The Global 5 and 10 Largest Angiotensin Receptor Antagonists Players: Market Share by Revenue in 2023
Figure 24. Angiotensin Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 25. Global Angiotensin Receptor Antagonists Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 26. North America Angiotensin Receptor Antagonists Sales Market Share by Country (2019-2030)
Figure 27. North America Angiotensin Receptor Antagonists Revenue Market Share by Country (2019-2030)
Figure 28. U.S. Angiotensin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Canada Angiotensin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Europe Angiotensin Receptor Antagonists Sales Market Share by Country (2019-2030)
Figure 31. Europe Angiotensin Receptor Antagonists Revenue Market Share by Country (2019-2030)
Figure 32. Germany Angiotensin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. France Angiotensin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. U.K. Angiotensin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Italy Angiotensin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Russia Angiotensin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Asia Pacific Angiotensin Receptor Antagonists Sales Market Share by Region (2019-2030)
Figure 38. Asia Pacific Angiotensin Receptor Antagonists Revenue Market Share by Region (2019-2030)
Figure 39. China Angiotensin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Japan Angiotensin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. South Korea Angiotensin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. India Angiotensin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Australia Angiotensin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Taiwan Angiotensin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Indonesia Angiotensin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Thailand Angiotensin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Malaysia Angiotensin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Philippines Angiotensin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Latin America Angiotensin Receptor Antagonists Sales Market Share by Country (2019-2030)
Figure 50. Latin America Angiotensin Receptor Antagonists Revenue Market Share by Country (2019-2030)
Figure 51. Mexico Angiotensin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Brazil Angiotensin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Argentina Angiotensin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Middle East & Africa Angiotensin Receptor Antagonists Sales Market Share by Country (2019-2030)
Figure 55. Middle East & Africa Angiotensin Receptor Antagonists Revenue Market Share by Country (2019-2030)
Figure 56. Turkey Angiotensin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. Saudi Arabia Angiotensin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 58. U.A.E Angiotensin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 59. Global Sales Market Share of Angiotensin Receptor Antagonists by Type (2019-2030)
Figure 60. Global Revenue Market Share of Angiotensin Receptor Antagonists by Type (2019-2030)
Figure 61. Global Angiotensin Receptor Antagonists Price (USD/MT) by Type (2019-2030)
Figure 62. Global Sales Market Share of Angiotensin Receptor Antagonists by Application (2019-2030)
Figure 63. Global Revenue Market Share of Angiotensin Receptor Antagonists by Application (2019-2030)
Figure 64. Global Angiotensin Receptor Antagonists Price (USD/MT) by Application (2019-2030)
Figure 65. Angiotensin Receptor Antagonists Value Chain
Figure 66. Angiotensin Receptor Antagonists Production Process
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Distributors Profiles
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
